Composition
- Active ingredients
- IBUPROFEN 40MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- IBUPROFEN 100MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SuspensionNDA019842-001 · Discontinued
- IBUPROFEN 100MG · Tablet, chewableNDA020135-002 · Discontinued
- IBUPROFEN 50MG · Tablet, chewableNDA020135-001 · Discontinued
- IBUPROFEN 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017463-004 · Discontinued
- IBUPROFEN 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017463-002 · Discontinued
- IBUPROFEN 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017463-005 · Discontinued
- IBUPROFEN 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017463-003 · Discontinued
- IBUPROFEN 100MG · TabletNDA020418-001 · Discontinued
- IBUPROFEN 40MG/ML · Suspension/dropsThis page
Official product information
At a glance
- Brand name
- Motrin
- Active substance
- ibuprofen
- Route
- Oral
- Dosage form
- Suspension/drops
- Applicant
- Mcneil
- Status
- Discontinued
- FDA approval
- 25 May 1995
- Application
- NDA020476-001